Page 1

Prenetics ™ Prenetics ' IM8 Reports Q2 2026 Revenue Growth of 288 % YoY ; Raises FY 2026 IM8 Revenue Guidance to $ 220-230 Million ; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond August 18 , 2026 • Total revenue of $ 46.5 million , up ~ 288 % YoY ( ~ 3.9x ) ; within the Company's guidance of $ 46-48 million • IM8 revenue of $ 45.0 million , up ~ 359 % YoY ( ~ 4.6x ) ; within the Company's guidance of $ 44-46 million , marking the sixth consecutive record quarter • July : strongest month ever at IM8 with $ 20.9 million $ 251 million annualized revenue run - rate ― • Initiates FY2027 guidance of $ 400 million + in IM8 revenue Webcast Information Prenetics will host a live earnings webcast at 8:30 a.m. Eastern time today to discuss the results . To join , please visit https://stocktwits.com / symbol / PRE . A replay will be made available on the Investor Relations website following the call . NEW YORK , Aug. 18 , 2026 ( GLOBE NEWSWIRE ) -- Prenetics Global Limited ( NASDAQ : PRE ) ( " Prenetics " or the " Company " ) , a leading consumer health company and parent of the Al - native direct - to - consumer wellness brand IM8 , co - founded by David Beckham , today reported its second quarter 2026 financial results . The complete results are presented in Prenetics ' Q2 2026 Letter to Shareholders ( the " Shareholder Letter " ) , which includes all financial tables , together with an accompanying Q2 2026 Investor Presentation ( the " Investor Presentation " ) , each dated August 18 , 2026 . Danny Yeung , Chief Executive Officer of Prenetics and Co - Founder of IM8 , said : " Twenty months ago , IM8 did not exist . This quarter it carried Prenetics to a sixth consecutive record , July became the biggest month in our history , and consolidated Adjusted Free Cash Flow turned positive for the first time and we expect it to remain positive from here . This is the single most important milestone we have been tracking since before the brand launched , arriving faster than I believed possible . Today we are raising full - year total revenue guidance to $ 220 to $ 230 million - and initiating 2027 IM8 revenue guidance of $ 400 million or more , with nothing from our upcoming product launches assumed . " " And beginning this quarter , we are changing how we report . With twenty months of data behind us , we are opening the books : a detailed Shareholder Letter , a full Investor Presentation with our monthly cohort economics and independent third - party card data , and a live earnings stream where we take questions directly . The reason is simple ― a business compounding this fast deserves to be examined , not summarized , and we would rather show you the machine than describe it . Everything is explained , cohort by cohort , in our Shareholder Letter and Investor Presentation - I encourage every investor to read it . " All financial tables , monthly cohort economics , customer acquisition metrics , independent third - party card data , and management's full discussion and outlook are contained in the Shareholder Letter and the Investor Presentation , which investors are encouraged to review in full . About Prenetics Prenetics Global Limited ( NASDAQ : PRE ) is a leading consumer health company on a mission to advance human health and longevity . Its flagship brand , IM8 , co - founded with David Beckham , is redefining premium daily nutrition through science - backed formulations - anchored by Daily Ultimate Essentials , a 90 - ingredient daily nutrition system that is NSF Certified for Sport and clinically studied . IM8 is the fastest - growing premium supplement brand ever recorded , reaching approximately $ 251 million in annualized run - rate revenue within 20 months of launch , shipping to 46 countries , and delivering well over 200,000 servings daily . IM8's ambassador and equity - partner roster includes David Beckham , Giannis Antetokounmpo , Aryna Sabalenka , Ollie Bearman , Jay Shetty , and Inter Miami CF. Learn more at prenetics.com and im8health.com . About IM8 IM8 is the pinnacle of premium core nutrition , born from a collaboration between David Beckham as a co - founding partner , and an elite team of scientists spanning medical professionals , academia and space science . Combining cutting - edge science with nature's most potent ingredients , IM8 delivers a holistic , science - backed approach to health , empowering you to live your most vibrant life . IM8's flagship product , Daily Ultimate Essentials , is an all - in - one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport , non - GMO , vegan , free from common allergens , and contains no artificial flavors , colors or sweeteners . IM8 is a subsidiary of Prenetics ( NASDAQ : PRE ) , a leading global health sciences company dedicated to advancing consumer health . To learn more about IM8 , please visit www.IM8health.com . Follow IM8 on Instagram at @ im8health for updates . Investor Relations Contact investors@prenetics.com PRE@mzgroup.us Angela Cheung Investor Relations / Corporate Finance